Company intelligence / Profile preview

Xmark Opportunity Funds

Greenwich, CT, USA

Ownership: Private
Development stage: Other

Overview

Xmark Opportunity Funds is a specialized investment firm focused on the life sciences and healthcare sectors. The firm manages a series of investment vehicles that provide growth capital to both public and private companies within the biotechnology, pharmaceutical, and medical technology industries. Xmark typically targets entities with innovative platforms and strong clinical potential, offering strategic guidance alongside financial support. Led by Mitchell Kaye, the firm leverages extensive industry experience to identify and capitalize on unique opportunities in the healthcare market. Its investment strategy encompasses a broad range of therapeutic areas and development stages.

Industry: Investors

Beyond the preview

Go deeper on Xmark Opportunity Funds.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xmark Opportunity Funds.

Explore the full profile